Z-1826-2012 Class I Terminated
FDA device recall Z-1826-2012 was initiated by Fresenius Medical Care Holdings, Inc. on Mar 29, 2012 and is designated Class I. Reason for recall: Risk of Alkalosis with acetate containing dialysis acid concentrates The recall status is terminated (terminated Jul 20, 2017).
Recall details
- Product Type
- Devices
- Report Date
- Jul 4, 2012
- Initiation Date
- Mar 29, 2012
- Termination Date
- Jul 20, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Fresenius NaturaLyte Liquid Acid Concentrate Product Codes: 08-0231-4, 08-1001-0, 08-1201-8, 08-1231-3, 08-1251-1, 08-1301-4, 08-2201-5, 08-2231-2, 08-2251-0, 08-2301-3,08-2351-8,08-3201-4,08-3231-1,08-3251-9,08-3301-2,08-4123-1, 08-4223-7, 08-4225-1' 08-4230-2, 08-4231-0, 08-4323-5, 08-4325-1, 13-1251-1, 13-2201-5, 13-2231-2, 13-2251-0, 13-3231-1,13-3251-9, 13-4123-1' 13-4220-1, 13-4225-1 ' 13-4325-1. For the treatment of acute and chronic renal failure during hemodialysis procedure.
Reason for recall
Risk of Alkalosis with acetate containing dialysis acid concentrates
Distribution pattern
Nationwide Distribution and the country of Guam.
Code information
All lots
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1826-2012
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026